46604 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 03
13:55 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Whitney Ijem ★☆☆☆☆ #3092 | Buy | $83.00→ $37.00-55.4% |
|
Sep 03
13:55 UTC
|
NTAP
NetApp
|
◎ Target | Mehdi Hosseini ★★★☆☆ #1126 | Neutral | $185.00→ $195.00+5.4% |
|
Sep 03
13:55 UTC
|
NTAP
NetApp
|
◎ Target | Matt Bryson ★★★☆☆ #1482 | Neutral | $150.00→ $170.00+13.3% |
|
Sep 03
13:55 UTC
|
ILMN
Illumina
|
◎ Target | Jasper Hellweg ★★★★☆ #618 | Buy | $180.00→ $235.00+30.6% |
|
Sep 03
13:55 UTC
|
HPE
Hewlett Packard Enterprise
|
◎ Target | Tim Long ★★☆☆☆ #2632 | Overweight | $67.00→ $79.00+17.9% |
|
Sep 03
13:55 UTC
|
GOLD
Gold.com
|
◎ Target | Brian McNamara ★★★☆☆ #2134 | Buy | $70.00→ $65.00-7.1% |
|
Sep 03
13:55 UTC
|
DRTS
Alpha Tau Medical
|
◎ Target | Lukas Shumway not yet tracked | Overweight | $17.00→ $30.00+76.5% |
|
Sep 03
13:55 UTC
|
AXON
Axon Enterprise
|
◎ Target | John Staszak ★★★★☆ #743 | Buy | $460.00→ $600.00+30.4% |
|
Sep 03
13:55 UTC
|
ADBE
Adobe
|
◎ Target | Saket Kalia ★★★☆☆ #1340 | Equal Weight | $250.00→ $295.00+18.0% |
|
Sep 03
13:55 UTC
|
RARE
Ultragenyx Pharmaceutical
|
↓ Downgrade | firm only | Outperform→ Market Perform | |
|
Sep 03
13:55 UTC
|
RARE
Ultragenyx Pharmaceutical
|
↓ Downgrade | firm only | Outperform→ Inline | $16.00 |
|
Sep 03
13:55 UTC
|
GGAL
Grupo Financiero Galicia
|
↓ Downgrade | firm only | Outperform→ Market Perform | |
|
Sep 03
13:55 UTC
|
FNLPF
Fresnillo
|
↓ Downgrade | firm only | Equal Weight→ Underweight | |
|
Sep 03
13:55 UTC
|
CCHGY
Coca-Cola HBC
|
↓ Downgrade | firm only | Hold | |
|
Sep 03
13:55 UTC
|
BMA
Macro Bank
|
↓ Downgrade | firm only | Outperform→ Market Perform | |
|
Sep 03
13:55 UTC
|
AGX
Argan
|
↑ Upgrade | Robert Brown ★☆☆☆☆ #3208 | Hold→ Buy | $600.00 |
|
Sep 03
12:55 UTC
|
WOOF
Petco Health and Wellness
|
◎ Target | Peter Benedict ★★★★☆ #963 | Neutral | $3.00→ $3.25+8.3% |
|
Sep 03
12:55 UTC
|
TEAM
Atlassian
|
◎ Target | Allan Verkhovski ★★★☆☆ #1087 | Buy | $180.00→ $230.00+27.8% |
|
Sep 03
12:55 UTC
|
SNOW
Snowflake
|
◎ Target | Kingsley Crane ★★★☆☆ #1724 | Buy | $325.00→ $450.00+38.5% |
|
Sep 03
12:55 UTC
|
SNOW
Snowflake
|
◎ Target | Mike Cikos ★★★☆☆ #1296 | Buy | $330.00→ $450.00+36.4% |
|
Sep 03
12:55 UTC
|
SNOW
Snowflake
|
◎ Target | Patrick Walravens ★★★★☆ #820 | Market Outperform | $408.00→ $488.00+19.6% |
|
Sep 03
12:55 UTC
|
SNOW
Snowflake
|
◎ Target | Brian White ★★★☆☆ #1841 | Buy | $380.00→ $450.00+18.4% |
|
Sep 03
12:55 UTC
|
SNOW
Snowflake
|
◎ Target | Gray Powell ★★★☆☆ #1092 | Buy | $340.00→ $424.00+24.7% |
|
Sep 03
12:55 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Raghuram Selvaraju not yet tracked | Buy | $50.00→ $25.00-50.0% |
|
Sep 03
12:55 UTC
|
RARE
Ultragenyx Pharmaceutical
|
◎ Target | Kristen Kluska ★☆☆☆☆ #3182 | Overweight | $103.00→ $33.00-68.0% |
|
Sep 03
12:55 UTC
|
PATH
UiPath
|
◎ Target | Scott Berg ★★★☆☆ #1589 | Buy | $15.00→ $22.00+46.7% |
|
Sep 03
12:55 UTC
|
NTSK
Netskope
|
◎ Target | Shrenik Kothari ★★★☆☆ #1193 | Outperform | $18.00→ $20.00+11.1% |
|
Sep 03
12:55 UTC
|
NTSK
Netskope
|
◎ Target | Gray Powell ★★★☆☆ #1092 | Buy | $17.00→ $18.00+5.9% |
|
Sep 03
12:55 UTC
|
NTSK
Netskope
|
◎ Target | Catharine Trebnick ★★★☆☆ #2015 | Buy | $18.00→ $19.00+5.6% |
|
Sep 03
12:55 UTC
|
MGNI
Magnite
|
◎ Target | Laura Martin ★★☆☆☆ #2845 | Buy | $25.00→ $30.00+20.0% |
|
Sep 03
12:55 UTC
|
JILL
J.Jill
|
◎ Target | Dana Telsey ★★★☆☆ #1689 | Market Perform | $14.00→ $18.00+28.6% |
|
Sep 03
12:55 UTC
|
GIII
G-III Apparel Group
|
◎ Target | Dana Telsey ★★★☆☆ #1689 | Market Perform | $38.00→ $32.00-15.8% |
|
Sep 03
12:55 UTC
|
DKNG
DraftKings
|
◎ Target | Ian Moore not yet tracked | Outperform | $27.00→ $29.00+7.4% |
|
Sep 03
12:55 UTC
|
AVGO
Broadcom
|
◎ Target | Harsh Kumar ★★★★☆ #773 | Outperform | $455.00→ $575.00+26.4% |
|
Sep 03
12:55 UTC
|
AVGO
Broadcom
|
◎ Target | Sajal Dogra not yet tracked | Buy | $500.00→ $600.00+20.0% |
|
Sep 03
12:55 UTC
|
AVGO
Broadcom
|
◎ Target | C.J. Muse not yet tracked | Overweight | $525.00→ $600.00+14.3% |
|
Sep 03
12:55 UTC
|
AIN
Albany International
|
◎ Target | Peter Arment ★★★★☆ #563 | Neutral | $64.00→ $75.00+17.2% |
|
Sep 03
12:55 UTC
|
ZTO
ZTO Express (Cayman)
|
↓ Downgrade | David Chen not yet tracked | Overweight→ Neutral | $22.00 |
|
Sep 03
12:55 UTC
|
SON
Sonoco Products
|
↓ Downgrade | George Staphos ★★☆☆☆ #2263 | Buy→ Neutral | $69.00→ $60.00-13.0% |
|
Sep 03
12:55 UTC
|
RARE
Ultragenyx Pharmaceutical
|
↓ Downgrade | firm only | Outperform→ In-Line | $16.00 |
|
Sep 03
12:55 UTC
|
RARE
Ultragenyx Pharmaceutical
|
↓ Downgrade | Joel Beatty ★★★★★ #232 | Outperform→ Neutral | $40.00→ $16.00-60.0% |
|
Sep 03
12:55 UTC
|
RARE
Ultragenyx Pharmaceutical
|
↓ Downgrade | Anupam Rama ★☆☆☆☆ #3017 | Overweight→ Neutral | $36.00 |
|
Sep 03
12:55 UTC
|
RARE
Ultragenyx Pharmaceutical
|
↓ Downgrade | Michael Turrin ★★★★☆ #944 | Overweight→ Equal Weight | $18.00 |
|
Sep 03
12:55 UTC
|
PCG
Pacific Gas & Electric
|
↓ Downgrade | Richard Sunderland ★★★☆☆ #1002 | Buy→ Hold | $17.00 |
|
Sep 03
12:55 UTC
|
MRNA
Moderna
|
↓ Downgrade | Simon Baker not yet tracked | Neutral→ Sell | $40.00→ $81.00+102.5% |
|
Sep 03
12:55 UTC
|
FLNC
Fluence Energy
|
↓ Downgrade | Christine Cho ★★★★☆ #855 | Equal Weight→ Underweight | $10.00 |
|
Sep 03
12:55 UTC
|
CVSA
Adtalem Global Education
|
↓ Downgrade | Jasper Bibb ★★★☆☆ #2207 | Buy→ Hold | $140.00 |
|
Sep 03
12:55 UTC
|
NVST
Envista
|
↑ Upgrade | Lilia-Celine Lozada not yet tracked | Neutral→ Overweight | $32.00 |
|
Sep 03
12:55 UTC
|
CPRT
Copart
|
↑ Upgrade | firm only | Neutral→ Overweight | $40.00 |
|
Sep 03
11:55 UTC
|
ALMS
Alumis
|
↓ Downgrade | Yatin Suneja ★★☆☆☆ #2783 | Buy→ Neutral |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.